Blood Assemblage Market Key Players, Competitive Landscape, Growth, Statistics, Revenue and Industry Analysis Report by

Comments · 19 Views

global blood assemblage market is expected to reach USD 7.82 Billion in 2028 and register a steady revenue CAGR of 6.2% over the forecast period, according to latest report published by Reports and Data.

 

Increasing investments for developing enhanced blood assemblage devices, increasing number of blood donation camps, and rising adoption of point-of-care testing are key factors boosting global market growth 

The c Key factors driving global market revenue growth are increasing prevalence of various diseases, rising number of accidents, organ transplantations and surgeries, and increasing number of product approvals. 

Blood assemblage is one of the most common methods used for diagnosing various healthcare conditions. In the recent years, there has been a rapid increase in various health conditions such as cardiovascular diseases and cancer across the globe. Blood is collected for various blood tests for diagnosis and treatment of diseases. Increasing prevalence of blood diseases such as anemia, blood clots, leukemia, and sickle cell disease and rising need for regular blood testing are fueling global market growth. In addition, increasing awareness about blood donation, rising need for blood transfusion in emergencies, road accidents, and surgeries, and increasing investments for developing cost-effective products are expected to fuel global market growth going ahead. 

Key companies profiled in the report include

Becton, Dickinson and Company, Terumo BCT, Inc., Fresenius Kabi AG, Grifols, Nipro Medical Corporation, Quest Diagnostics, Macopharma S.A., Smiths Medical, Kawasumi Laboratories, Retractable Technologies, Liuyang Sanli Medical Technology Development, F.L. Medical S.R.L, AB Medical, Micsafe Medical Group Limited, CML Biotech, Lmb Technologie GmbH, and Greiner Holding AG 

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/4183

The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Blood Assemblage market.

The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.

Order this Report @ https://www.reportsanddata.com/report-pricing/4183

The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.

The key geographical regions analyzed in the market report are:

  • North America (U.S.A., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Blood Assemblage Market Segmentation based on Types:

Product Outlook (Revenue, USD Billion, 2018-2028)

  • Blood Assemblage Tubes
    • Plasma/Whole-Blood Tubes
    • EDTA Tubes
    • Heparin Tubes
    • Coagulation Tubes
    • Glucose Tubes
    • ESR Tubes
    • Serum Tubes
    • Vacuum Tubes
    • Non-vacuum Tubes
  • Needles Syringes
  • Blood Bags
  • Blood Assemblage Systems/Monitors
  • Lancets

Method Outlook (Revenue, USD Billion, 2018-2028)

  • Manual
  • Automated

Application Outlook (Revenue, USD Billion, 2018-2028)

  • Diagnostics
    • Infectious Diseases
    • Non-infectious Diseases
  • Therapeutics

End Use Outlook (Revenue, USD Billion, 2018-2028)

  • Hospitals, Ambulatory Surgical Centers, Nursing Homes
  • Diagnostic Pathology Laboratories
  • Blood Banks
  • Others

Some key highlights from the report:

  • Based on product, the blood assemblage tubes segment is expected to account for significant revenue share over the forecast period owing to high prevalence of various chronic diseases, increasing blood testing, availability of different testing tubes for diagnosis of different diseases, and increasing focus on developing more advanced tubes for collecting blood. 
  • Among the application segment, the diagnostics segment is expected to account for significantly larger share during 2021-2028 owing to increasing prevalence of diabetes, cancer, cardiovascular disorders, high usage of blood assemblage devices for diagnosing infections, and increasing awareness about regular health checkups.  
  • Based on end use, the hospitals, ambulatory surgical centers, nursing homes segment is expected to account for largest revenue share during the forecast period owing to increasing prevalence of various diseases, large number of patient admissions for accidents, trauma, and other emergencies, and rising number of surgeries and organ transplantation. 
  • Europe is expected to account for significant revenue share over the forecast period owing to increasing prevalence of chronic diseases, availability of advanced healthcare facilities, rising number of accidents and emergencies, and increasing blood testing volume. In addition, increasing awareness about blood donation and early detection of diseases, increasing number of clinical trials, and rising investments in research and development activities are boosting market growth in Europe. 
  • Asia Pacific market revenue is expected to expand at a rapid CAGR during 2021-2028 owing to increasing healthcare expenditure, improving healthcare infrastructure, high patient pool, and rising number of blood donation events, campaigns organized by various public and private organizations. Other factors such as rising per capita income, increasing investments for developing advanced devices for collecting blood, increasing number of road accidents and surgeries are fueling Asia Pacific market growth. 

Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/4183

Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.

Explore More Industry Research by Reports and Data:

Magnetic Resonance, Computed Tomography And Nuclear Medicine Imaging Market @ https://www.biospace.com/article/magnetic-resonance-computed-tomography-and-nuclear-medicine-imaging-market-trends-revenue-key-players-growth-share-and-forecast-till-2028/

Immunodiagnostic Reagent Market @ https://www.biospace.com/article/immunodiagnostic-reagent-market-analysis-statistics-revenue-demand-and-trend-analysis-research-report-by-2028/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

 

 

 

 

 

Comments